Chiesi Group Reaffirms Its EcoVadis Platinum Medal

For the second consecutive year, Chiesi Group has been awarded the Platinum Medal by EcoVadis, ranking among the top 1% of companies worldwide for outstanding performance in Environment, Ethics,...

Show more

Bringing Sustainability and Strategy together to create Shared Value: Insights from Chiesi’s 2023 Sustainability Report

Chiesi Group's Sustainability Report 2023 highlights impacts on strategic areas such as Patients, Planet, People and Prosperity while anticipating regulatory changes. Patients: Chiesi invested...

Show more

Chiesi Group Unveils Innovations in Respiratory Care, Patient Insights into Decentralization of a Clinical Trial and Developments in Carbon Minimal Inhaler Project at ERS Congress 2024

  At the 2024 European Respiratory Society Congress (ERS), Chiesi Group will convene two symposia to highlight the importance of patient centricity in managing asthma and COPD Chiesi Group...

Show more

Chiesi Group’s new Biotech Center of Excellence brings the future of medicine to Parma

Chiesi Group is making a strategic investment of € 400 million to establish its new Biotech Center of Excellence in Parma. The Center is designed to integrate the entire supply chain,...

Show more

Chiesi and Gossamer Bio Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pulmonary Arterial Hypertension and Other Respiratory Indications

Strategic collaboration to leverage Chiesi's legacy of respiratory leadership and Gossamer Bio's development expertise in pulmonary hypertension. Gossamer to receive $160 million development...

Show more

Oak Hill Bio and Chiesi Group Announce First Patient Enrolled in the Resumed Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants

Design of multi-center study is based on previous Phase 2a clinical data, which showed a decrease in the occurrence of severe bronchopulmonary dysplasia (BPD) OHB-607 has the potential to be the...

Show more

Chiesi Achieves Platinum Medal from EcoVadis

As a testament to its steadfast commitment to sustainability, Chiesi proudly announces its achievement of the Platinum medal from EcoVadis, with a score of 78/100. This important recognition places...

Show more

Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices

Highlights from Chiesi Group’s 2023 financial report: Sales increased to over €3 billion, up 10% compared to 2022 (+12% @CER), driven by the Rare business unit growth (65% @CER), and...

Show more

Chiesi’s investment in women equal pay achieves the Fair Pay certification

On this International Women's Day Chiesi joins the commitment of the UN for 2024, "Invest in Women: Accelerate Progress," and proudly announces a significant milestone in its dedication to gender...

Show more

PAST, PRESENT, FUTURE

Chiesi Farmaceutici S.p.A. Via Palermo 26, Parma 16 February — 18 May 2024 “The greatest commitment has been to embrace and respond to change, quickly adapting to changing internal...

Show more
PREV
NEXT
1
/
10
Chiesi Group Reaffirms Its EcoVadis Platinum Medal
NEWS / 13 Dicembre 2024
For the second consecutive year, Chiesi Group has been awarded the Platinum Medal by EcoVadis, ranking among the top 1% of companies worldwide for outstanding performance in Environment, Ethics,...
CONTINUE
Great Place To Work and Fortune Name Chiesi Group No. 23 in 2024 World’s Best...
PRESS / 14 Novembre 2024
Chiesi is the only European pharmaceutical company and the first Italian company ever to be included in the World’s Best Workplaces™ The accolade reflects Chiesi's dedication to...
CONTINUE
Chiesi Group’s near and long-term science-based emissions reduction targets have been...
NEWS / 25 Ottobre 2024
In a significant advancement in its commitment to combating climate change and promoting sustainability, Chiesi Group is proud to announce that the Science Based Targets initiative (SBTi) has...
CONTINUE
Sustainability Manifesto
We live in a time of great change. The equilibrium of a planet exploited beyond its limits is continuously evolving. We ourselves have changed the way we live and view society. The most fragile and vulnerable pay the price: those who are often left behind in this rush to make progress.
FIND OUT MORE
Transparency

Guaranteeing the highest ethical standards is a daily priority for Chiesi in every aspect of its business. This means doing business on the basis of the principles of legality, fairness, integrity, responsibility and transparency.

FIND OUT MORE